FDA GLP-1 Vision Loss Warning: What Ozempic Users Should Know
The FDA has ordered all GLP-1 drugs, including Ozempic, Wegovy, Mounjaro and Zepbound, to carry a warning about NAION, a rare eye condition that can cause sudden vision loss. Here is how big the risk is and what patients should do.